Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert G. Jr. Spignesi Sells 10,824 Shares

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 10,824 shares of the company's stock in a transaction that occurred on Tuesday, July 8th. The shares were sold at an average price of $3.51, for a total transaction of $37,992.24. Following the sale, the chief executive officer directly owned 886,686 shares of the company's stock, valued at approximately $3,112,267.86. This represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Rapid Micro Biosystems Trading Down 2.9%

RPID stock traded down $0.10 during midday trading on Thursday, reaching $3.37. 68,661 shares of the company's stock traded hands, compared to its average volume of 196,931. Rapid Micro Biosystems, Inc. has a 52-week low of $0.63 and a 52-week high of $4.04. The stock has a market cap of $147.71 million, a P/E ratio of -3.27 and a beta of 1.32. The stock's 50-day moving average is $3.29 and its 200 day moving average is $2.55.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported ($0.26) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.01. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. The business had revenue of $7.21 million during the quarter, compared to analysts' expectations of $6.63 million. As a group, research analysts expect that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.

Hedge Funds Weigh In On Rapid Micro Biosystems

A number of hedge funds have recently modified their holdings of the company. ABG WTT Global Life Science Capital Partners GP Ltd boosted its position in shares of Rapid Micro Biosystems by 78.0% in the first quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company's stock worth $4,880,000 after purchasing an additional 810,000 shares during the period. Parkman Healthcare Partners LLC bought a new position in shares of Rapid Micro Biosystems in the first quarter worth approximately $1,942,000. Renaissance Technologies LLC boosted its position in shares of Rapid Micro Biosystems by 122.9% in the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock worth $165,000 after purchasing an additional 100,942 shares during the period. Informed Momentum Co LLC bought a new position in shares of Rapid Micro Biosystems in the first quarter worth approximately $467,000. Finally, Evernest Financial Advisors LLC bought a new position in shares of Rapid Micro Biosystems during the first quarter worth $347,000. 52.60% of the stock is currently owned by institutional investors.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.